| Date Filed | Type | Description |
| 11/16/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/18/2022 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 10/03/2022 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 08/09/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/02/2021 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 07/26/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/26/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/26/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/26/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/26/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/26/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/23/2021 |
4
| COUGHLIN CHRISTOPHER J (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 42,347 shares
@ $0
Disposed/sold 2,294 options to buy
@ $138.86, valued at
$318.5k
Disposed/sold 2,706 options to buy
@ $167.97, valued at
$454.5k
Disposed/sold 2,343 options to buy
@ $155.01, valued at
$363.2k
|
|
| 07/23/2021 |
4
| SARIN ARADHANA (EVP, CFO) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 120,253 shares
@ $0 |
|
| 07/23/2021 |
4
| FRIEDMAN PAUL A (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 12,840 shares
@ $0 |
|
| 07/23/2021 |
4
| Reinsdorf Judith A (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 14,150 shares
@ $0 |
|
| 07/23/2021 |
4
| Dunsire Deborah (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 14,629 shares
@ $0 |
|
| 07/23/2021 |
4
| Carino Tanisha (EVP & CCAO) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 59,226 shares
@ $0 |
|
| 07/23/2021 |
4
| Mollen John T (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 15,336 shares
@ $0
Disposed/sold 2,785 options to buy
@ $159.7, valued at
$444.8k
Disposed/sold 2,294 options to buy
@ $138.86, valued at
$318.5k
Disposed/sold 2,343 options to buy
@ $155.01, valued at
$363.2k
|
|
| 07/23/2021 |
4
| Brennan David R (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 20,873 shares
@ $0
Disposed/sold 2,343 options to buy
@ $155.01, valued at
$363.2k
Disposed/sold 2,706 options to buy
@ $167.97, valued at
$454.5k
Disposed/sold 2,294 options to buy
@ $138.86, valued at
$318.5k
|
|
| 07/23/2021 |
4
| Goff Brian (EVP & Chief Commercial Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 150,832 shares
@ $0
Disposed/sold 21,750 options to buy
@ $100.14, valued at
$2.2M
|
|
| 07/23/2021 |
4
| Chiniara Ellen (EVP & Chief Legal Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 116,850 shares
@ $0 |
|
| 07/23/2021 |
4
| Bazarko Daniel (SVP, Controller, CAO) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 60,207 shares
@ $0
Disposed/sold 5,300 options to buy
@ $131.25, valued at
$695.6k
Disposed/sold 5,111 options to buy
@ $176.8, valued at
$903.6k
Disposed/sold 3,943 options to buy
@ $180.37, valued at
$711.2k
Disposed/sold 2,912 options to buy
@ $180.28, valued at
$525k
|
|
| 07/23/2021 |
4
| Franchini Indrani Lall (EVP, Chief Compliance Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 116,075 shares
@ $0
Disposed/sold 25,165 options to buy
@ $100.14, valued at
$2.5M
|
|
| 07/23/2021 |
4
| Nader Francois (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 13,921 shares
@ $0 |
|
| 07/23/2021 |
4
| Rummelt Andreas (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 28,109 shares
@ $0
Disposed/sold 2,785 options to buy
@ $159.7, valued at
$444.8k
Disposed/sold 2,294 options to buy
@ $138.86, valued at
$318.5k
Disposed/sold 3,425 options to buy
@ $96.35, valued at
$330k
Disposed/sold 3,237 options to buy
@ $85.75, valued at
$277.6k
Disposed/sold 2,343 options to buy
@ $155.01, valued at
$363.2k
|
|
| 07/23/2021 |
4
| HANTSON LUDWIG (CEO) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 580,809 shares
@ $0
Disposed/sold 56,762 options to buy
@ $118.83, valued at
$6.7M
|
|
| 07/23/2021 |
4
| ORLOFF JOHN J (EVP, Research & Development) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 146,511 shares
@ $0 |
|
| 07/22/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/22/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 07/22/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 07/22/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 07/22/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 07/22/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 07/22/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
|